prescrib
chines
medicin
practition
treat
variou
inflammatori
disord
includ
ra
extractsconstitu
two
herb
attenu
anim
arthriti
inhibit
signal
previous
report
rl
herbal
formula
compos
two
herb
could
inhibit
variou
compon
signal
pathway
therefor
examin
rl
could
improv
clinic
condit
collageninduc
arthriti
cia
rat
model
well
establish
studi
human
ra
investig
involv
signal
effect
rl
present
studi
investig
vivo
efficaci
rl
cia
rat
rat
immun
bovin
type
ii
collagen
began
develop
arthriti
first
week
initi
manifest
arthriti
erythema
swell
ankl
joint
follow
inflamm
metatars
interphalang
joint
diseas
progress
evalu
measur
paw
swell
volum
indic
degre
inflamm
order
evalu
antiarthrit
efficaci
rl
paw
volum
chang
quantifi
use
plethysmometri
three
dose
rl
significantli
amelior
paw
swell
end
experi
signific
reduct
paw
volum
observ
group
treat
rl
mgkg
indomethacin
mgkg
nonsteroid
antiinflammatori
drug
nsaid
use
posit
control
fig
overal
arthriti
sever
cia
rat
commonli
assess
macroscop
clinic
score
begin
day
arthriti
score
cia
rat
increas
progress
reach
last
week
administr
rl
significantli
attenu
clinic
sign
arthriti
indic
signific
reduct
mean
arthriti
score
fig
repres
photograph
show
morpholog
chang
hind
paw
rat
differ
group
day
shown
fig
begin
day
cia
rat
gain
significantli
less
weight
normal
rat
averag
food
intak
cia
rat
significantli
reduc
rl
effect
improv
food
intak
amelior
weight
loss
caus
cia
moreov
observ
advers
reaction
found
rltreat
group
entir
experiment
period
fig
e
rl
attenu
radiograph
damag
cia
rat
radiograph
examin
talocrur
joint
reveal
tissu
swell
bone
matrix
resorpt
osteophyt
format
bone
eros
joint
margin
cia
rat
pathogen
chang
observ
normal
rat
rl
markedli
amelior
soft
tissu
swell
degre
joint
damag
fig
signific
reduct
radiograph
score
observ
rltreat
group
fig
rl
improv
histolog
paramet
cia
rat
order
determin
whether
rl
prevent
articular
destruct
talocrur
joint
analys
histolog
histolog
examin
show
massiv
infiltr
inflammatori
cell
pannu
invas
cartilag
damag
subchondr
bone
eros
cia
rat
fig
histolog
score
individu
group
shown
fig
rl
inhibit
signal
cia
rat
previou
studi
demonstr
rl
could
inhibit
b
pathway
lpsstimul
murin
raw
human
cell
increas
expressionact
signal
compon
b
cia
rat
demonstr
involv
patholog
cia
rl
reduc
upregul
protein
level
b
phosphocjun
cia
joint
tissu
fig
b
upon
ligand
bind
recruit
sever
adaptor
lead
activ
transcript
b
initi
product
proinflammatori
cytokin
effector
cytokin
contribut
pathogenesi
cia
rl
mitig
upregul
level
proinflammatori
elev
level
antiinflammatori
sera
joint
tissu
lysat
fig
rl
also
lower
level
sera
fig
activ
signal
induc
oxid
stress
result
imbal
antioxid
system
excess
product
proinflammatori
mediat
exagger
oxid
stress
ra
result
immun
cell
activ
sinc
two
herb
rl
contain
variou
natur
antioxid
determin
effect
rl
activ
endogen
antioxid
enzym
cia
rat
rl
treatment
high
dose
significantli
rejuven
declin
activ
antioxid
enzym
sod
cat
gshpx
sera
fig
liver
tissu
cia
rat
fig
adapt
immun
respons
inhibit
signal
shown
lower
synovi
express
serum
concentr
cia
model
order
character
effect
rl
immun
respons
level
joint
tissu
sera
determin
rl
significantli
mitig
level
sera
joint
tissu
lysat
cia
rat
fig
b
studi
show
splenic
proport
pathogen
cell
play
import
role
pathogenesi
ra
correl
directli
level
serum
arthrit
mice
line
decreas
serum
rl
also
reduc
cell
proport
splenocyt
fig
inhibit
product
pmaandionomycinactiv
splenocyt
isol
cia
rat
fig
humor
respons
autoantigen
essenti
develop
eros
arthriti
rl
inhibit
ciistimul
prolifer
splenocyt
isol
cia
rat
fig
significantli
reduc
igg
antibodi
level
sera
fig
discuss
current
drug
treatment
option
ra
like
nsaid
diseasemodifi
antirheumat
drug
satisfactori
low
efficaci
advers
effect
toxic
new
therapeut
agent
low
toxic
high
efficaci
explor
research
seek
altern
complementari
therapeut
agent
multitarget
chines
medicin
rl
tradit
remedi
inflammatori
disord
includ
ra
compos
yingshi
jinyinhua
low
toxic
yingshi
use
make
variou
food
product
jinyinhua
treat
food
asian
countri
shown
oral
administr
extract
yingshi
attenu
sever
cia
rat
without
show
observ
advers
effect
jinyinhua
togeth
herb
demonstr
improv
condit
cia
mice
present
studi
demonstr
herbal
formula
rl
significantli
improv
clinic
condit
throughout
cours
diseas
cia
rat
without
observ
advers
effect
evid
support
rl
potenti
safe
effect
antira
agent
sever
studi
propos
novel
strategi
treatment
ra
cia
regul
activ
immun
cell
well
level
certain
cytokin
eg
gmcsf
signal
pathway
regul
wide
rang
proinflammatori
cytokin
activ
variou
immun
cell
believ
one
novel
therapeut
target
ra
manag
previous
report
rl
could
inhibit
variou
signal
compon
therefor
investig
rl
effect
signallingrel
event
cia
rat
activ
ligand
damag
synovi
tissu
upon
ligand
bind
signal
activ
transcript
factor
b
heterodim
cfoscjun
heterodim
activ
transcript
factor
result
product
inflammatori
mediat
eg
provid
posit
feedback
signal
pathway
result
persist
inflamm
favour
induct
autoimmun
studi
found
rl
could
inhibit
signal
demonstr
suppress
protein
express
b
phosphocjun
joint
tissu
phosphoryl
key
transcript
factor
signal
essenti
product
proinflammatori
cytokin
rl
inhibit
signal
also
evidenc
reduc
product
proinflammatori
cytokin
regul
transcript
factor
b
sera
joint
tissu
cia
rat
proinflammatori
cytokin
could
induc
oxid
stress
lead
declin
activ
endogen
antioxid
rl
rejuven
declin
activ
antioxid
enzym
sod
cat
gshpx
sera
liver
tissu
cia
rat
signal
also
take
part
immun
respons
product
autoimmun
antibodi
upon
collagen
immun
found
less
mice
wild
type
mice
present
studi
rl
found
abl
lower
level
sera
joint
tissu
cia
rat
observ
support
reduct
pathogen
cell
product
spleen
cell
addit
rl
could
reduc
igg
antibodi
product
inhibit
antigenstimul
prolifer
splenocyt
suggest
attenu
signal
possibl
one
molecular
mechan
antiarthrit
effect
rl
cia
rat
fig
reduct
proport
cell
may
also
respons
effect
rl
sever
studi
demonstr
besid
cell
modul
activ
immun
cell
eg
macrophag
monocyt
b
cell
dendrit
cell
treg
cell
may
also
potenti
therapeut
approach
ra
manag
multicompon
multitarget
natur
chines
medicin
believ
herbal
formula
may
also
affect
immun
cell
studi
need
investig
effect
formula
signal
pathway
well
compon
immun
system
conclus
rl
improv
clinic
condit
cia
rat
without
overt
advers
effect
associ
inhibit
signal
find
provid
pharmacolog
basi
tradit
use
formula
control
ra
studi
perform
develop
rl
safe
effect
modern
antira
agent
prepar
rl
herbal
materi
prepar
describ
previous
briefli
g
yingshi
g
jinyinhua
mix
minc
macer
l
absolut
ethanol
h
reflux
h
twice
supernat
filter
concentr
freezedri
produc
rl
yield
control
qualiti
establish
hplc
chromatogram
rl
quantifi
content
gallic
acid
chlorogen
acid
supplementari
figur
supplementari
materi
previou
report
anim
treatment
male
wistar
rat
g
suppli
chines
univers
hong
kong
hous
standard
condit
humid
hdark
free
access
water
chow
fortyeight
rat
randomli
divid
six
group
eight
five
group
immun
intraderm
base
tail
back
g
bovin
type
ii
collagen
chondrex
redmond
wa
usa
acet
acid
emulsifi
equal
volum
incomplet
freund
adjuv
ifa
chondrex
redmond
wa
usa
day
boost
inject
g
collagenifa
suspens
given
manner
day
day
immun
group
intragastr
ig
administ
mg
rlkgday
mg
indomethacinkgday
salin
respect
normal
control
ig
administ
salin
retroorbit
blood
sampl
anaesthesia
perform
variou
time
point
sera
collect
centrifug
g
min
day
rat
fast
overnight
kill
anaesthet
overdos
take
radiograph
hind
limb
left
paw
tissu
whole
joint
includ
synovium
adjac
tissu
bone
pulver
use
mortar
pestl
fill
liquid
nitrogen
homogen
mm
trishcl
sodium
deoxychol
mm
nacl
mm
edta
ph
mm
phenylmethylsulfonyl
fluorid
mm
naf
mm
na
vo
gml
aprotinin
gml
leupetin
gml
pepstatin
right
hind
limb
collect
histolog
examin
singl
cell
suspens
splenocyt
prepar
spleen
describ
red
blood
cell
suspens
remov
treatment
trisnh
cl
solut
liver
tissu
dissect
homogen
icecold
salin
use
ultraturrax
homogen
experiment
protocol
approv
ethic
committe
hong
kong
baptist
univers
experiment
procedur
conduct
accord
principl
express
declar
helsinki
guid
care
use
laboratori
anim
publish
us
nation
institut
health
everi
effort
made
reduc
number
anim
use
minim
pain
distress
macroscop
score
cia
hind
limb
score
scale
normal
mild
definit
ankl
erythema
swell
limit
individu
digit
moder
ankl
erythema
swell
entir
limb
erythema
swell
includ
digit
maxim
inflam
limb
multipl
joint
involv
arthriti
score
sum
score
two
hind
limb
maximum
quantifi
oedema
hind
paw
volum
measur
use
plethysmomet
hind
limb
radiograph
taken
day
evalu
use
scale
maximum
normal
soft
tissu
swell
soft
tissu
swell
earli
joint
eros
sever
bone
eros
signific
osteophyt
format
histolog
analysi
right
hind
limb
fix
neutral
formalin
one
week
decalcifi
edta
paraformaldehyd
day
decalcifi
sampl
dehydr
alcohol
embed
paraffin
section
thick
talocrur
joint
section
stain
hematoxylin
eosin
mount
glass
slide
histolog
analysi
light
microscopi
histopatholog
chang
joint
evalu
base
histolog
paramet
inflamm
synovi
hyperplasia
pannu
format
eros
cartilagebon
use
scale
normal
synovium
hypertrophi
cell
infiltr
pannu
cartilag
eros
major
cartilag
subchondr
bone
eros
loss
joint
integr
ankylosi
immunoblot
quantifi
joint
tissu
lysat
assess
western
blot
analysi
describ
previous
briefli
protein
lysat
subject
sdspage
electrotransf
onto
nitrocellulos
membran
block
nonfat
milk
tbst
membran
incub
design
primari
antibodi
overnight
membran
incub
antimous
antirabbit
secondari
antibodi
specif
immunoreact
band
detect
use
enhanc
chemiluminesc
ecl
detect
kit
invitrogen
carlsbad
ca
usa
follow
manufactur
instruct
splenocyt
cultur
splenocyt
isol
anim
maintain
rpmi
medium
contain
heatinactiv
foetal
bovin
serum
fb
antibiot
penicillin
streptomycin
co
splenocyt
prolifer
assay
splenocyt
suspens
cellswel
well
plate
cultur
rpmi
medium
contain
gml
heatdenatur
bovin
cii
pretreat
min
h
mtt
mgml
ad
h
supernat
remov
centrifug
min
l
dmso
ad
absorb
nm
measur
use
micropl
spectrophotomet
express
percentag
normal
control
splenocyt
activ
assay
splenocyt
cellsml
stimul
pma
gml
ionomycin
gml
h
concentr
supernat
determin
elisa
ebiosci
inc
ca
usa
follow
manufactur
instruct
flow
cytometr
analysi
splenocyt
cellsml
stimul
pma
gml
ionomycin
gml
h
brefeldin
bfa
gml
h
cell
extracellularli
stain
fitcconjug
fix
permeabil
label
intracellularli
peconjug
percentag
stain
cell
measur
use
fac
instrument
cytokin
chemokin
antioxid
anticollagen
antibodi
assay
cytokin
chemokin
level
quantifi
milliplex
map
rat
cytokinechemokin
panel
merck
millipor
antioxid
antimous
cii
igg
level
determin
elisa
kit
ebiosci
inc
ca
usa
follow
manufactur
instruct
result
present
mean
sem
data
analyz
oneway
anova
comparison
two
group
perform
use
dunnett
multipl
comparison
test
posthoc
analysi
statist
analys
carri
use
graphpad
prism
version
graphpad
softwar
san
diego
ca
usa
p
consid
statist
signific
